Zobrazeno 1 - 10
of 61
pro vyhledávání: '"AP Nademanee"'
Autor:
DS Snyder, RS Negrin, MR O'Donnell, NJ Chao, MD Amylon, GD Long, AP Nademanee, AS Stein, PM Parker, EP Smith
Publikováno v:
Blood. 84(5)
Ninety-four consecutive patients with chronic myelogenous leukemia in first clinical chronic phase, median age of 34.0 years (range, 6.8 to 52.4 years), with a histocompatible sibling donor, were treated with fractionated total body irradiation (1,32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e62f0782ec4d9c8fadc6288417ec579
https://pubmed.ncbi.nlm.nih.gov/8068956
https://pubmed.ncbi.nlm.nih.gov/8068956
Publikováno v:
Blood. 84(3)
Over a 6-year period, 275 patients were treated with autologous bone marrow transplantation (auto-BMT) for advanced-stage malignant lymphoma. After BMT, clonal chromosomal abnormalities were detected in hematopoietic cells from 10 patients. All 10 ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccdbd188d0bf44eeb80180aaf00f1f4c
https://pubmed.ncbi.nlm.nih.gov/8043877
https://pubmed.ncbi.nlm.nih.gov/8043877
Autor:
DS Snyder, NJ Chao, MD Amylon, J Taguchi, GD Long, RS Negrin, AP Nademanee, MR O'Donnell, GM Schmidt, AS Stein
Publikováno v:
Blood. 82(9)
Ninety-nine consecutive patients with acute leukemia in first complete remission under age 50 (median age 27 years; age range 1 to 47 years) with a histocompatible sibling donor were treated with fractionated total body irradiation (1,320 cGy) and hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f40fd13814b30486aa341dcf89246a
https://pubmed.ncbi.nlm.nih.gov/8219241
https://pubmed.ncbi.nlm.nih.gov/8219241
Autor:
NJ Chao, SJ Forman, GM Schmidt, DS Snyder, MD Amylon, PN Konrad, AP Nademanee, MR O'Donnell, PM Parker, AS Stein
Publikováno v:
Blood. 78(8)
Fifty-three patients with high-risk acute lymphoblastic leukemia (ALL) under age 50 with a histocompatible sibling donor received high-dose radiochemotherapy followed by allogeneic bone marrow transplantation (BMT). The high-risk factors used to iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aad12b9f468684670063425ab0b2def5
https://pubmed.ncbi.nlm.nih.gov/1912575
https://pubmed.ncbi.nlm.nih.gov/1912575
Autor:
SJ Forman, MR O'Donnell, AP Nademanee, DS Snyder, PJ Bierman, GM Schmidt, JL Fahey, AS Stein, PM Parker, KG Blume
Publikováno v:
Blood. 70:587-588
We report the treatment outcome of allogeneic bone marrow transplantation in ten patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Six patients are alive and well for 6 to 30 months (median 19 months) after transplantation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21de27cd3e7e52386f32f6d3eb947380
https://doi.org/10.1182/blood.v70.2.587.bloodjournal702587
https://doi.org/10.1182/blood.v70.2.587.bloodjournal702587
Autor:
Zain J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Tsai NC; Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA., Palmer J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.; Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA., Simpson J; Clinical Trials Office, City of Hope National Medical Center, Duarte, CA., Adhikarla V; Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA., Bading JR; Department of Immunology and Theranostics, City of Hope National Medical Center, Duarte, CA., Yazaki P; Department of Immunology and Theranostics, City of Hope National Medical Center, Duarte, CA., Smith EP; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Dandapani S; Department of Radiology, City of Hope National Medical Center, Duarte, CA., Song JY; Department of Pathology, City of Hope National Medical Center, Duarte, CA., Karras NA; Department of Pediatrics, City of Hope National Medical Center, Duarte, CA., Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Salhotra A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Nademanee AP; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Smith DL; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Yamauchi D; Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA., Poku EK; Radiopharmacy, City of Hope National Medical Center, Duarte, CA., Biglang-Awa VE; Radiopharmacy, City of Hope National Medical Center, Duarte, CA., Colcher D; Department of Immunology and Theranostics, City of Hope National Medical Center, Duarte, CA., Shively JE; Department of Immunology and Theranostics, City of Hope National Medical Center, Duarte, CA., Wu AM; Department of Immunology and Theranostics, City of Hope National Medical Center, Duarte, CA., Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Wong J; Department of Radiology, City of Hope National Medical Center, Duarte, CA., Thomas S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
Publikováno v:
Blood advances [Blood Adv] 2024 Sep 24; Vol. 8 (18), pp. 4812-4822.
Autor:
Song JY; Department of Pathology, City of Hope National Medical Center, Duarte, California. josong@coh.org.; Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California., Perry AM; Department of Pathology, University of Michigan, Ann Arbor, Michigan., Herrera AF; Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California.; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California., Chen L; Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California.; Department of Information Sciences, City of Hope National Medical Center, Duarte, California., Skrabek P; Department of Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada., Nasr MR; Department of Pathology, SUNY Upstate Medical University, Syracuse, New York., Ottesen RA; Department of Diabetes & Cancer Discovery Science, City of Hope National Medical Center, Duarte, California., Nikowitz J; Department of Diabetes & Cancer Discovery Science, City of Hope National Medical Center, Duarte, California., Bedell V; Department of Pathology, City of Hope National Medical Center, Duarte, California.; Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California., Murata-Collins J; Department of Pathology, City of Hope National Medical Center, Duarte, California., Li Y; Department of Pathology, City of Hope National Medical Center, Duarte, California., McCarthy C; Department of Diabetes & Cancer Discovery Science, City of Hope National Medical Center, Duarte, California., Pillai R; Department of Pathology, City of Hope National Medical Center, Duarte, California.; Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California., Wang J; Integrative Genomics Core, City of Hope National Medical Center, Duarte, California., Wu X; Integrative Genomics Core, City of Hope National Medical Center, Duarte, California., Zain J; Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California.; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California., Popplewell L; Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California.; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California., Kwak LW; Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California.; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California., Nademanee AP; Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California.; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California., Niland JC; Department of Diabetes & Cancer Discovery Science, City of Hope National Medical Center, Duarte, California., Scott DW; British Columbia Research Center, Vancouver, British Columbia, Canada., Gong Q; Department of Pathology, City of Hope National Medical Center, Duarte, California., Chan WC; Department of Pathology, City of Hope National Medical Center, Duarte, California.; Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California., Weisenburger DD; Department of Pathology, City of Hope National Medical Center, Duarte, California.; Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Mar 15; Vol. 27 (6), pp. 1671-1680. Date of Electronic Publication: 2021 Jan 07.
Autor:
Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California. Electronic address: aherrera@coh.org., Chen L; Department of Computational and Quantitative Medicine, City of Hope, Duarte, California., Khajavian S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Chase M; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Darrah J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Maloney D; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Medical Oncology Division, University of Washington, Seattle, Washington., Ho VT; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Soiffer RJ; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Antin JH; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Nademanee AP; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California., Chen YB; Division of Bone Marrow Transplantation, Massachusetts General Hospital, Boston, Massachusetts., Armand P; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Shadman M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Medical Oncology Division, University of Washington, Seattle, Washington.
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2019 Dec; Vol. 25 (12), pp. 2383-2387. Date of Electronic Publication: 2019 Aug 05.
Autor:
Chen RW; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA. rchen@coh.org., Palmer JM; Department of Information Sciences, City of Hope National Medical Center, Duarte, CA, USA., Tomassetti S; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA., Popplewell LL; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA., Alluin J; Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope National Medical Center, Duarte, CA, USA., Chomchan P; Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope National Medical Center, Duarte, CA, USA., Nademanee AP; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA., Siddiqi T; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA., Tsai NC; Department of Information Sciences, City of Hope National Medical Center, Duarte, CA, USA., Chen L; Department of Information Sciences, City of Hope National Medical Center, Duarte, CA, USA., Zuo F; Clinical Trial Office, City of Hope National Medical Center, Duarte, CA, USA., Abary R; Clinical Trial Office, City of Hope National Medical Center, Duarte, CA, USA., Cai JL; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.; Kaiser Permanente Southern California Bone Marrow Transplantation Program, Los Angeles, CA, USA., Herrera AF; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA., Rossi JJ; Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope National Medical Center, Duarte, CA, USA., Rosen ST; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope National Medical Center, Duarte, CA, USA., Forman SJ; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA., Kwak LW; Toni Stephenson Lymphoma Center, Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Holmberg LA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Department of Medicine, University of Washington, Seattle, WA, USA.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2018 Jun 28; Vol. 11 (1), pp. 87. Date of Electronic Publication: 2018 Jun 28.
Autor:
Micallef IN; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Stiff PJ; Division of Hematology/Oncology, Loyola University, Chicago, Illinois., Nademanee AP; City of Hope Comprehensive Cancer Center, Duarte, California., Maziarz RT; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina., Stadtmauer EA; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Kaufman JL; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia., McCarty JM; Department of Internal Medicine, Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia., Vargo R; Sanofi, Cambridge, Massachusetts., Cheverton PD; Sanofi, Cambridge, Massachusetts., Struijs M; Sanofi, Naarden, The Netherlands., Bolwell B; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., DiPersio JF; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address: jdipersi@wustl.edu.
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2018 Jun; Vol. 24 (6), pp. 1187-1195. Date of Electronic Publication: 2018 Feb 02.